Brown Advisory Inc. Lowers Stake in Encompass Health Corporation $EHC

Brown Advisory Inc. reduced its position in Encompass Health Corporation (NYSE:EHC) by 9.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 912,762 shares of the company’s stock after selling 100,033 shares during the period. Brown Advisory Inc.’s holdings in Encompass Health were worth $96,881,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in EHC. WPG Advisers LLC raised its holdings in Encompass Health by 73.3% in the fourth quarter. WPG Advisers LLC now owns 324 shares of the company’s stock worth $34,000 after purchasing an additional 137 shares in the last quarter. Flagship Harbor Advisors LLC acquired a new position in Encompass Health in the 4th quarter worth approximately $37,000. Assetmark Inc. increased its holdings in Encompass Health by 88.1% in the 3rd quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after buying an additional 140 shares during the period. Caitong International Asset Management Co. Ltd increased its holdings in Encompass Health by 36,200.0% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after buying an additional 362 shares during the period. Finally, Covestor Ltd increased its holdings in Encompass Health by 24.4% in the 4th quarter. Covestor Ltd now owns 540 shares of the company’s stock worth $57,000 after buying an additional 106 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Insider Activity

In other news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the transaction, the executive vice president owned 24,755 shares in the company, valued at $2,588,382.80. This trade represents a 2.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.80% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Weiss Ratings reiterated a “buy (b-)” rating on shares of Encompass Health in a report on Monday, June 8th. Leerink Partners set a $152.00 price target on shares of Encompass Health in a report on Friday, May 22nd. Barclays lowered their price objective on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. TD Cowen initiated coverage on Encompass Health in a research report on Thursday, May 28th. They issued a “buy” rating and a $125.00 price objective on the stock. Finally, Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $143.86.

Encompass Health Trading Up 0.0%

Shares of NYSE:EHC opened at $101.49 on Monday. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99. The firm has a market capitalization of $10.07 billion, a price-to-earnings ratio of 16.94, a price-to-earnings-growth ratio of 2.21 and a beta of 0.72. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.17 and a quick ratio of 1.17. The business’s 50 day moving average price is $104.31 and its 200-day moving average price is $104.59.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same quarter last year, the firm posted $1.37 EPS. The business’s revenue was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, equities research analysts forecast that Encompass Health Corporation will post 5.97 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a dividend of $0.19 per share. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is 12.69%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.